pharmaphorum October 4, 2024
Eloise McLennan

Investment and strategic partnerships are the lifeblood of innovation in healthcare, driving groundbreaking discoveries and accelerating the development of life-changing therapies. And so, it was no surprise that the 2024 LSX USA Congress in Boston attracted life sciences innovators and decision-makers from around the world, eager to explore the latest trends shaping the industry.

Among those attendees was pharmaphorum’s editor-in-chief, Jonah Comstock, who took to the floor to uncover the trends and talking points set to influence investment decisions in the coming months.

In this special episode of the pharmaphorum podcast, Jonah sat down with Deep Dive editor Eloise McLennan to discuss key takeaways from the LSX conference....

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Conferences / Podcast, Investments, Pharma / Biotech, Trends
How private investment can improve senior-housing options
How Crunchbase AI Is Forecasting Unicorns With 95% Accuracy
AI competition is eating the world
Private equity firm to buy Walgreens for $10B, report says
Flosonics Medical Secures C$7.5M to Scale Wearable Ultrasound Tech | StartUp Health Insights: Week of Mar 4, 2025

Share This Article